Study by the University of Bonn shows that patients survive significantly longer with combination chemotherapy Cancer researchers at the University of Bonn have reported significant progress in the treatment of glioblastoma. About one third of all patients suffer from a particular variant of this most common and aggressive brain tumor. Survival of these patients treated […]Continue Reading ...
Study could help identify patients with glioblastoma who are most likely to respond to immunotherapy. Columbia researchers have learned why some glioblastomas–the most common type of brain cancer–respond to immunotherapy. The findings could help identify patients who are most likely to benefit from treatment with immunotherapy drugs and lead to the development of more broadly […]Continue Reading ...
A study led by researchers at the Washington University School of Medicine has shed light on why more males than females develop and die from the deadly brain cancer, glioblastoma. Giovanni Cancemi | Shutterstock The team identified distinct molecular signatures in tumors taken from men and women that helped to explain the disparity in treatment […]Continue Reading ...
Glioblastoma, a deadly brain cancer that has grabbed headlines for claiming the lives of Sens. Edward Kennedy and John McCain, could be “tricked” into sparing more of its victims. A team of University of Arizona researchers who looked for genetic differences between glioblastoma cells from long- and short-term survivors discovered that those who survived longer […]Continue Reading ...
Today, Penn Medicine is announcing the newest Translational Center of Excellence (TCE) in the Abramson Cancer Center, focused on Glioblastoma Multiforme, the most common and lethal form of brain cancer. The team will investigate new immune therapies for glioblastoma and, in particular, design and test new CAR T cell therapies. This involves engineering patients’ T […]Continue Reading ...
Researchers at The University of Texas Medical Branch at Galveston have successfully harnessed a Zika virus vaccine under development to target and kill the brain cancer known as glioblastoma. The findings are currently available in MBio. The Zika virus can cause microcephaly, a condition where the fetal brain doesn’t fully develop when a pregnant woman […]Continue Reading ...
Scientists with the Virginia Tech Carilion Research Institute say a gene involved in the body’s circadian rhythms is a potential target for therapies to help patients with a deadly form of brain cancer known as glioblastoma. This discovery, to be published in the journal Scientific Reports on Tuesday, Sept. 11, points to a subtype of […]Continue Reading ...
The death today of Sen. John McCain (R-Ariz.) sheds a new light on glioblastoma, a form of brain cancer that the American Brain Tumor Association estimated would be diagnosed in nearly 13,000 people this year. “Glioblastoma makes up about 60 percent of what we call primary brain tumors, tumors that start within the brain,” said […]Continue Reading ...
(HealthDay)—Neoadjuvant administration of programmed cell death protein 1 (PD-1) blockade seems to enhance local and systemic antitumor immune response in glioblastoma, according to a study published online Feb. 11 in Nature Medicine. Timothy F. Cloughesy, M.D., from the University of California in Los Angeles, and colleagues examined immune responses and survival after neoadjuvant and/or adjuvant […]Continue Reading ...
Dec 12 2018 The European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group and Protagen AG today announced a collaboration to utilize Protagen’s Cancer Immunotherapy Array to identify autoantibody biomarkers that investigate the immunological profile and immuno-competence of long-term Glioblastoma survivors. Glioblastoma is the most common glial brain tumor with an annual […]Continue Reading ...
Glioblastoma is a serious and incurable brain cancer. Patients receiving this diagnosis typically have 11-20 months to live. One of the main difficulties in treating this cancer is that its cells quickly build up a resistance to chemotherapy. In the upcoming issue of Nucleic Acids Research, Professor Rotem Karni and his team at Hebrew University’s […]Continue Reading ...
A specific protein called TEAD1 is an important regulator of tumor migration in glioblastoma, the most common brain tumor in adults, and deactivating this protein may stop tumor cells from migrating away from the main tumor mass, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 1 in […]Continue Reading ...
Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients’ immune systems stop the spread of glioblastoma — an aggressive form of brain cancer with very few current treatment options. Led by neuro-oncologist Clement Pillainayagam, MD, the phase II clinical trial is testing an investigational vaccine […]Continue Reading ...
An aggressive brain tumor (glioblastoma), illustrated based on magnetic resonance data. Credit: Karl-Heinz Nenning Glioblastoma is a highly aggressive brain cancer that predominantly affects people in their 50s, 60s and 70s. Even under the best available care, half of the patients die within one year after diagnosis, and very few live on for more than […]Continue Reading ...
August 13, 2018 Glioblastoma brain tumors can have an unusual effect on the body’s immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body’s defenses. Where the T-cells go has been unclear, even as immunotherapies are increasingly employed to stimulate the body’s natural ability to fight invasive […]Continue Reading ...
- U.S.-based patient advocacy organizations received majority of pharma donations, finds study
- UCL and AIIMS collaborates to increase academic and student exchange
- Mechanism behind how diabetes causes muscle loss revealed
- Hepatocellular carcinoma diagnosis, prognosis and treatment may improve by identifying a protein
- The American Heart Association issues new reference toolkit for healthcare providers
- Studies explore physiological dangers that climate change will have on animal life
- Penn study reveals increase in health-related internet searches before ER visits
- Intensive therapy during early stages of MS leads to better long-term outcomes
- Prenatal Fluconazole Exposure Increases Neonatal Risks
- Mental Health Screening: MedlinePlus Lab Test Information
- Study suggests birth mechanics are part of the process that leads to autism
- Unhealthy diet linked to poor mental health
- Study gives a snapshot of crocodile evolution
- Research finds steep rise in self-poisonings among young people
- American Gastroenterological Association announces “AGA Future Leaders Program”
- Scientists uncover new mechanisms regulating neural stem cells
- Combinations of certain insecticides turn out to be lethal for honeybees
- AHA News: Why Are Black Women at Higher Risk of Dying From Pregnancy Complications?
- NIMH » Anxiety Disorders
- Autistic people urgently need access to tailored mental health support